• Degarelix Acetate: Advancing Androgen Deprivation in Prostat

  2026-05-30

  Degarelix acetate, a third-generation GnRH antagonist, introduces rapid and sustained testosterone suppression without inducing the initial testosterone surge typical of GnRH agonists. This innovation addresses key clinical challenges in prostate cancer therapy, offering improved safety and efficacy profiles for patients requiring medical castration.

• DGLA-Induced Ferroptosis via ACSL4 Reprogramming in AML Cell

  2026-05-29

  This study uncovers how exogenous dihomo-γ-linolenic acid (DGLA) induces ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight ferroptosis as a potential therapeutic strategy in AML and provide detailed mechanistic insight into the interplay between lipid metabolism and cell death pathways.

• 3D Electrophysiology of Cardiac Organoids with Shell MEAs

  2026-05-29

  The reference study introduces programmable shell microelectrode arrays (MEAs) for comprehensive three-dimensional mapping of electrical activity in human cardiac organoids. This technology enables high-content spatiotemporal analysis, facilitating improved modeling of cardiac arrhythmias and pharmacological responses.

• EZ Cap™ Cre mRNA (m1Ψ): Precision mRNA for Advanced Gene Edi

  2026-05-28

  EZ Cap™ Cre mRNA (m1Ψ) brings bench-to-bedside gene editing closer with its stability, low immunogenicity, and rapid, efficient Cre recombinase expression. Learn how this APExBIO mRNA solution empowers next-generation delivery workflows and troubleshooting for reproducible, high-performance results.

• Anti Reverse Cap Analog: Enhancing mRNA Capping and Translat

  2026-05-28

  Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, delivers orientation-specific capping that doubles synthetic mRNA translation efficiency and boosts stability for advanced mRNA therapeutics and gene editing workflows. This article details practical protocol enhancements, troubleshooting strategies, and new frontiers catalyzed by ARCA, as exemplified in targeted mRNA delivery for neuroprotection post-stroke.

• PLGA-Based Nano-Adjuvant Enhances Mucosal Immunity in Chicks

  2026-05-27

  This study introduces a novel PLGA-based nano-adjuvant that significantly improves both mucosal and systemic immune responses in chicks vaccinated against H9N2 avian influenza. By targeting the intestinal tract and promoting IgA production, the nano-adjuvant addresses longstanding limitations of traditional vaccine strategies, offering new avenues for effective avian disease control.

• Z-DEVD-FMK: Precision Caspase-3 Inhibitor Workflows in Apopt

  2026-05-27

  Z-DEVD-FMK empowers researchers to dissect apoptotic and necrotic pathways with high specificity, combining irreversible caspase-3 inhibition and calpain suppression. Its solubility, dual-action mechanism, and reproducible performance make it indispensable for advanced apoptosis assays and neuroprotection models.

• Cy5.5 NHS Ester: Near-Infrared Fluorescent Dye for Protein C

  2026-05-26

  Cy5.5 NHS ester (non-sulfonated) enables ultra-sensitive, deep-tissue fluorescence imaging and robust amino group labeling for proteins, peptides, and oligonucleotides. This article provides actionable workflow guidance, troubleshooting insights, and comparative context for researchers seeking reproducibility and high signal-to-noise in in vivo and translational applications.

• Mubritinib-HSA Binding: Implications for Drug Delivery and C

  2026-05-26

  This study elucidates the molecular recognition between mubritinib and human serum albumin (HSA), revealing moderate affinity and a static quenching mechanism that alters HSA's structure and function. These findings inform how protein binding can impact the pharmacokinetics and bioavailability of anti-cancer agents, with methodological parallels to research on other small-molecule inhibitors like 2-[4-(2-methylpropyl)phenyl]propanoic acid (ibuprofen).

• Sabutoclax: Potent Pan-Bcl-2 Inhibitor for Apoptosis Researc

  2026-05-25

  Sabutoclax is a next-generation pan-Bcl-2 inhibitor with high affinity for multiple anti-apoptotic proteins, enabling precise apoptosis induction in cancer research. Its validated efficacy in both in vitro and in vivo models positions it as a key tool for studying apoptosis-based therapies.

• BCKAs Aerobically Activate HIF1α Signaling in Vascular Cells

  2026-05-25

  This study uncovers that branched chain α-ketoacids (BCKAs) can activate HIF1α signaling under normal oxygen conditions in primary vascular cells, mediated by suppression of PHD2 and altered metabolic pathways. These findings offer novel insight into the metabolic regulation of vascular cell phenotype, with implications for pulmonary hypertension and vascular biology research.

• ARCA Cy5 EGFP mRNA (5-moUTP): Precision Tools for mRNA Deliv

  2026-05-24

  ARCA Cy5 EGFP mRNA (5-moUTP) stands out as a dual-fluorescent, 5-methoxyuridine modified mRNA for direct, real-time analysis of mRNA delivery and localization in mammalian cells. Its compatibility with advanced delivery systems and innate immune suppression makes it indispensable for researchers seeking reproducible, quantitative mRNA transfection and translation efficiency assays.

• HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis: Advanced

  2026-05-23

  Unlock the full potential of HOBt (1-Hydroxybenzotriazole) for precise, high-yield peptide synthesis and complex amide bond formation. This guide integrates real-world protocols, troubleshooting insights, and the latest literature to help researchers maximize stereochemical fidelity and streamline experimental workflows.

• Cy5-UTP (Cyanine 5-UTP): Reliable Fluorescent RNA Labeling i

  2026-05-22

  This article provides a scenario-driven, evidence-based exploration of Cy5-UTP (Cyanine 5-UTP), SKU B8333, for advanced RNA labeling in biomedical research. It addresses common workflow challenges in in vitro transcription, FISH, and RNA probe synthesis, demonstrating how APExBIO’s Cy5-UTP enhances experimental sensitivity, reproducibility, and data interpretation.

• Cy5.5 NHS Ester: Advanced Protein Labeling for In Vivo Imagi

  2026-05-22

  Cy5.5 NHS ester (non-sulfonated) empowers researchers with precise, high-sensitivity labeling for in vivo fluorescence imaging and protein conjugation. This guide translates recent neuromodulation breakthroughs and experimental best practices into actionable workflow enhancements, troubleshooting tips, and protocol optimizations.

16488 records 1/1100 page Next 12345 下5页 Last page